Nitto Denko Avecia, Inc. has 913 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 2.2%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.
As of September 2025
Nitto Denko Avecia
workforce metrics
Headcount
913
Avg. Salary
$104.5k
Tenure
4.3yr
Growth Rate
2.2%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of Nitto Denko Avecia annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of Nitto Denko Avecia annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?